Skip to content

Time reference in aphasic subjects. Test for Assessing Reference of Time

Time reference in aphasic subjects. Test for Assessing Reference of Time - TART (Test for Assessing Reference of Time)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32433
Enrollment
30
Registered
2009-12-15
Start date
2010-02-11
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurologische aandoeningen: afasie CVA

Interventions

None listed

Sponsors

Rijksuniversiteit Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy controls Inclusion criteria - age between 18 and 75 - right-handed - native speaker of Dutch ;Patients: Inclusion criteria: - aphasic due to an acute non-congenital brain damage, like CVA or contusio cerebri - native speaker of Dutch - age between 18 and 75 - minimally three months post onset

Exclusion criteria

Exclusion criteria: Healthy controls - neurological diseases or language and/or speech problems - hearing or visual problems that influence the administration of the test ;patients: - psychiatric diseases - cognitive problems that influence the administration of the test (to be judged by the treating psychologist) - visual or hearing problems that influence the administration of the test

Design outcomes

Primary

MeasureTime frame
The final goal of this research is to come to a better understanding of the problems that patients with aphasia have with time aspects in the production of sentences and the comprehension of sentences. Results of this study will be compared to the outcomes of studies in at least 11 other languages within the TART-project. The final goal of the TART is to increase the knowledge in tense processing. This knowledge serves to get a clearer view on the underlying deficits in aphasia and this knowledge for its part is important in developing diagnostic and therapeutic materials.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)